Table 6: Assessment of Treatment Tolerability at Visits 2 and 3 (Baseline Population n = 4,092)

Assessment of Treatment Tolerability
Investigator (%) Patient (%)
Visit 2 Visit 3 Visit 2 Visit 3
Very good 33.1 40.0 31.1 38.2
Good 54.4 50.1 52.1 48.9
Fair 9.6 6.0 12.9 8.2
Bad 1.6 0.9 2.3 1.4
Very bad 0.2 0.2 0.5 0.5
No data 1.1 2.8 1.1 2.8
Total 100 100 100 100